Short-term venlafaxine <i>v.</i> lithium monotherapy for bipolar type II major depressive episodes: Effectiveness and mood conversion rate

Abstract

These findings suggest that short-term venlafaxine monotherapy may provide effective antidepressant treatment for bipolar II depression without a statistically significant increase in hypomanic symptoms relative to lithium.